Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Novak

Showing results (211-220 of 230) with videos related to

Pageof 23
Sort By:
The American Journal of Gastroenterology|August 14, 2024
US National Estimates of Contemporary Mortality Rates in Patients With Ulcerative Colitis Undergoing ColectomyNewaz Shubidito Ahmed, Satchel Krawchuk, Katherine A Buhler, et al.
Blood|July 8, 2011
The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in miceAnthony J Courey, Jeffrey C Horowitz, Kevin K Kim, et al.
JAMIA Open|October 23, 2025
Ethical sourcing in the context of health data supply chain management: a value sensitive design approachCamille Nebeker, Jean Christophe Bélisle-Pipon, Benjamin X Collins, et al.
Inflammatory Bowel Diseases|May 3, 2018
Real-time Interobserver Agreement in Bowel Ultrasonography for Diagnostic Assessment in Patients With Crohn's Disease: An International Multicenter StudyEmma Calabrese, Torsten Kucharzik, Christian Maaser, et al.
Inflammatory Bowel Diseases|March 23, 2017
Long-term Maintenance of Clinical, Endoscopic, and Radiographic Response to Ustekinumab in Moderate-to-Severe Crohn's Disease: Real-world Experience from a Multicenter Cohort StudyChristopher Ma, Richard N Fedorak, Gilaad G Kaplan, et al.
Alimentary Pharmacology & Therapeutics|March 3, 2017
Clinical, endoscopic and radiographic outcomes with ustekinumab in medically-refractory Crohn's disease: real world experience from a multicentre cohortC Ma, R N Fedorak, G G Kaplan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 4, 2025
Diagnostic Accuracy of Noninvasive Biomarkers and Imaging for Evaluating Postoperative Recurrence in Crohn's DiseaseSunil Samnani, Christina M Ray, Priyanka Gill, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
Preoperative Ustekinumab Treatment Is Not Associated With Increased Postoperative Complications in Crohn's Disease: A Canadian Multi-Centre Observational Cohort StudyHang Hock Shim, Christopher Ma, Paulo G Kotze, et al.
Alimentary Pharmacology & Therapeutics|August 1, 2018
Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel diseasePaulo G Kotze, Christopher Ma, Abdulelah Almutairdi, et al.
Inflammatory Bowel Diseases|January 30, 2025
Generalizability of Randomized Controlled Trials to Routine Clinical Care in Ulcerative ColitisTarun Chhibba, Alexandra Frolkis, Levi R Stein, et al.
Pageof 23

Showing results (211-220 of 230) with videos related to

Sort By:
Pageof 23
The American Journal of Gastroenterology|August 14, 2024
US National Estimates of Contemporary Mortality Rates in Patients With Ulcerative Colitis Undergoing ColectomyNewaz Shubidito Ahmed, Satchel Krawchuk, Katherine A Buhler, et al.
Blood|July 8, 2011
The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in miceAnthony J Courey, Jeffrey C Horowitz, Kevin K Kim, et al.
JAMIA Open|October 23, 2025
Ethical sourcing in the context of health data supply chain management: a value sensitive design approachCamille Nebeker, Jean Christophe Bélisle-Pipon, Benjamin X Collins, et al.
Inflammatory Bowel Diseases|May 3, 2018
Real-time Interobserver Agreement in Bowel Ultrasonography for Diagnostic Assessment in Patients With Crohn's Disease: An International Multicenter StudyEmma Calabrese, Torsten Kucharzik, Christian Maaser, et al.
Inflammatory Bowel Diseases|March 23, 2017
Long-term Maintenance of Clinical, Endoscopic, and Radiographic Response to Ustekinumab in Moderate-to-Severe Crohn's Disease: Real-world Experience from a Multicenter Cohort StudyChristopher Ma, Richard N Fedorak, Gilaad G Kaplan, et al.
Alimentary Pharmacology & Therapeutics|March 3, 2017
Clinical, endoscopic and radiographic outcomes with ustekinumab in medically-refractory Crohn's disease: real world experience from a multicentre cohortC Ma, R N Fedorak, G G Kaplan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 4, 2025
Diagnostic Accuracy of Noninvasive Biomarkers and Imaging for Evaluating Postoperative Recurrence in Crohn's DiseaseSunil Samnani, Christina M Ray, Priyanka Gill, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
Preoperative Ustekinumab Treatment Is Not Associated With Increased Postoperative Complications in Crohn's Disease: A Canadian Multi-Centre Observational Cohort StudyHang Hock Shim, Christopher Ma, Paulo G Kotze, et al.
Alimentary Pharmacology & Therapeutics|August 1, 2018
Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel diseasePaulo G Kotze, Christopher Ma, Abdulelah Almutairdi, et al.
Inflammatory Bowel Diseases|January 30, 2025
Generalizability of Randomized Controlled Trials to Routine Clinical Care in Ulcerative ColitisTarun Chhibba, Alexandra Frolkis, Levi R Stein, et al.
Pageof 23